The congress of the World Medicine Park, the first global forum devoted to medical sciences, this year focusing on dealing with pain. Innovative aspects discussed at the congress included the future of analgesic therapy based on genetic medicine for increasingly personalized cures, said Jordi Moya Riera, president of the congress.
"What we have seen over these days was an intense period of sharing and teamwork involving clinical specialists, researchers, companies and Institutions to discuss the major challenge of pain," says Guido Fanelli, Professor of Anesthesiology and Reanimation at the University of Parma, amongst the main supporters of the WMP.
Need to improve patient understanding
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze